Goat anti-Mouse IgG Antibody (HRP)

Catalog No. ABIN376241

Quick Overview for Goat anti-Mouse IgG Antibody (HRP) (ABIN376241)

Target: IgG

Clonality: Polyclonal

Conjugate: HRP

Application: ELISA, Immunohistochemistry (IHC), Western Blotting (WB)

Isotype: IgG

Product Details

Reactivity: Mouse

Host: Goat

Specificity: Reacts with mouse IgG 1, IgG 2a, IgG 2b and IgG 3 as demonstrated by ELISA and flow cytometry.

Characteristics: Source: Pooled antisera from goats hyperimmunized with mouse IgG paraproteins.
To insure lot-to-lot consistency, each batch of product is tested by ELISA, PCFIA and/or flow cytometry for conformance with characteristics of a standard reference reagent.

Purification: Affinity chromatography on mouse IgG 3 covalently linked to agarose.

Application Details

Application Notes: Working Dilution:
1:4,000-1:8,000
Representative data are included in this product insert.

Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.

Restrictions: For Research Use only

Handling

Format: Liquid

Handling Advice: Avoid repeated freezing and thawing. Dilute only prior to immediate use
Centrifuge product if not completely clear after standing at room temperature.
Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

Storage: 4 °C

References

Sonnleitner, Prelog, Sonnleitner, Hinterbichler, Halbfurter, Kopecky, Almanzar, Koblmüller, Sturmbauer, Feist, Horres, Posch, Walder: "Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host." in: Nature communications, Vol. 13, Issue 1, pp. 2560, (2022) (PubMed).

Sonnleitner, Prelog, Jansen, Rodgarkia-Dara, Gietl, Schönegger, Koblmüller, Sturmbauer, Posch, Almanzar, Jury, Loney, Tichy, Nowotny, Walder: "Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients." in: Transboundary and emerging diseases, Vol. 69, Issue 3, pp. 1596-1605, (2022) (PubMed).

Flümann, Rehkämper, Nieper, Pfeiffer, Holzem, Klein, Bhatia, Kochanek, Kisis, Pelzer, Ahlert, Hauer, da Palma Guerreiro, Ryan, Reimann, Riabinska, Wiederstein, Krüger, Deckert, Altmüller, Klatt et al.: "An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities. ..." in: Blood cancer discovery, Vol. 2, Issue 1, pp. 70-91, (2021) (PubMed).

Merten, Fischer, Simon, Zhang, Schröder, Peters, Letombe, Hennen, Schrage, Bödefeld, Vermeiren, Gillard, Mohr, Lu, Brüstle, Gomeza, Kostenis: "Repurposing HAMI3379 to Block GPR17 and Promote Rodent and Human Oligodendrocyte Differentiation." in: Cell chemical biology, Vol. 25, Issue 6, pp. 775-786.e5, (2019) (PubMed).

Gao, Yallampalli, Yallampalli: "Gestational protein restriction increases angiotensin II production in rat lung." in: Biology of reproduction, Vol. 88, Issue 3, pp. 64, (2013) (PubMed).

Kamphuis, Shafique, Meijerhof, Stegmann, Wilschut, de Haan: "Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats." in: Vaccine, (2013) (PubMed).

Chen, Lin, Wang: "Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach." in: Clinical biochemistry, (2011) (PubMed).

Kim, Welsch, Yi, Lemon: "Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III." in: Journal of virology, Vol. 85, Issue 13, pp. 6645-56, (2011) (PubMed).

Target Details

Target: IgG

Target Type: Antibody